Cannabis Extraction Market

American farmers sold USD 259.1 million of floral hemp for extraction in 2025, at USD 35.80 a pound, the largest use of the crop, the US Department of Agriculture’s National Hemp Report of 16 April 2026 shows, yet from about 12 November 2026 finished hemp products holding more than 0.4 milligrams of total THC per container stop counting as hemp under Public Law 119-37. The cannabis extraction market covers the cannabinoid oils, distillates, isolates, hydrocarbon concentrates and solventless resins drawn from cannabis and hemp, valued at their first sale out of the extraction step, including toll processing fees. Douglas Insights sizes it at USD 6.75 billion in 2025, from about 1,850 tonnes of finished extract at USD 3,650 a kilogram, and at USD 9.74 billion in 2035, a revenue CAGR (compound annual growth rate) of 3.73%. The study sits beside our Medical Marijuana Market and Cannabis Infused Drinks Market reports, and shares methods with our Glycerol Extracts Market and Plant Based Supplement Market studies in our healthcare coverage; every figure follows the Douglas Insights research methodology.

Which cannabis extraction methods earn the most: hydrocarbon, ethanol, CO2 or solventless?

Hydrocarbon extraction with butane and propane earns the most, 36.0% of 2025 value or USD 2.43 billion, a Douglas Insights estimate. Solventless rosin and ice water hash grow fastest, 5.8% a year, from USD 810.3 million to USD 1.42 billion.

Hydrocarbon extraction leads at USD 2.43 billion because closed-loop butane and propane systems make live resin, shatter, badder and sauce, the concentrates that sell at the highest prices per gram in licensed stores. It grows 4.0% a year to USD 3.60 billion as live resin cartridges take share from distillate cartridges. Ethanol extraction, USD 1.82 billion or 27.0%, runs large batches of dried biomass at low cost per kilogram and supplies most of the distillate that goes into edibles, beverages and standard vape cartridges; it grows 3.0% a year because distillate prices keep falling. Supercritical and subcritical carbon dioxide (CO2) extraction, USD 1.28 billion, grows 3.3% a year on demand for solvent-free oils in medical products, tinctures and capsules, where buyers and regulators prefer no hydrocarbon residue.

Solventless rosin and ice water hash, USD 810.3 million, grow fastest at 5.8% a year to USD 1.42 billion. Pressing with heat or separating trichomes in ice water needs no solvent licence and sells as a craft product at a premium, Douglas Insights estimates. Other methods and post-processing, USD 405.1 million, cover short-path distillation, chromatography, isolation and winterisation sold as separate services, growing 2.8% a year. Method values for 2035 sum to USD 9.78 billion, 0.47% above the USD 9.74 billion headline, inside our 2.5% tolerance.

Value by extract type and end product

By extract type, THC distillate holds about 34% of 2025 value, hydrocarbon concentrates and live resin 30%, CO2 and full-spectrum oils 14%, solventless resin 12%, and CBD isolate and crude 10%, Douglas Insights estimates. By end product, vape cartridges and disposable pens take about 46% of extract value, dabbable concentrates 22%, edibles and beverages 17%, tinctures, capsules and medical oils 11%, and topicals 4%.

What drives cannabis extraction volume up 5.2% a year?

Cannabis extraction value grows 3.73% a year because extract volume rises 5.2% a year, from about 1,850 tonnes in 2025 to 3,070 tonnes in 2035, while the average price per kilogram falls 1.4% a year, Douglas Insights estimates.

Three forces lift volume, all Douglas Insights estimates unless a source is linked. The shift of consumers from flower to vapes and concentrates adds 2.1 points a year, medical and export channels add 1.6 points, and new legal markets and hemp ingredient demand add 1.4 points; compounded, 1.021 x 1.016 x 1.014 gives the 5.2% volume leg. The price leg is set out in the pricing section below.

Vapes and concentrates take share from flower: 2.1 points

Format shift adds 2.1 points a year. In Michigan, the only large regulator that splits sales by product, vape cartridges sold USD 52.40 million and concentrates USD 15.56 million in December 2025, about 25% of USD 269.27 million of adult-use sales, the Cannabis Regulatory Agency’s December 2025 monthly report shows; the share held at about 25% in January 2026, its January 2026 report shows. Michigan’s adult-use sales reached about USD 3.18 billion in 2025 on the cumulative totals in those reports, our arithmetic. Every gram sold as a cartridge or a dab has passed through an extractor, so a one-point shift of retail value from flower to extracts adds more than a point to extraction volume.

Medical and export channels: 1.6 points

Medical demand adds 1.6 points. Germany imported 201.1 tonnes of medical cannabis in 2025, against 71.1 tonnes in 2024, on Federal Institute for Drugs and Medical Devices (BfArM) data reported by Krautinvest on 3 March 2026. Curaleaf’s international revenue rose 63% to USD 172.5 million in 2025, its results of 26 February 2026 show, and Aurora’s global medical cannabis revenue rose 18% to CAD 288.6 million in its year to 31 March 2026, its results of 11 June 2026 show. Most imports are flower today, but medical systems buy oils and capsules with exact doses, made with CO2 or ethanol extraction under pharmaceutical good manufacturing practice, so each new medical patient lifts extract demand.

New markets and hemp ingredients: 1.4 points

New markets add 1.4 points. Health Canada counted 41.9 million units of cannabis extracts sold through non-medical channels and 1.56 million through medical channels from July to December 2025, against 72.7 million units of dried cannabis, its market data page updated 21 October 2026 shows. United States farmers harvested 16,880 acres of floral hemp in the open in 2025, up 43%, and the crop was worth USD 574 million, up 49%, the USDA National Hemp Report shows. Tilray’s revenue rose 11% to USD 915.5 million in its year to 31 May 2026, its results of 28 July 2026 show. We take less than a third of the hemp crop growth into the forecast, because the new federal hemp definition removes intoxicating hemp products from November 2026.

What holds back cannabis extraction: commodity distillate, the hemp redefinition or Schedule I status?

Three restraints slow cannabis extraction: falling wholesale and retail prices, the federal hemp redefinition that takes effect in November 2026, and the Schedule I status that still covers marijuana extract, Douglas Insights estimates.

Price compression is the largest brake on value. Colorado’s marijuana sales fell to USD 1.32 billion in 2025 from USD 1.40 billion in 2024, about 5.8%, the Colorado Department of Revenue’s sales reports show, and Cresco Labs’ revenue fell about 9.5% to USD 655.8 million in 2025, its results of 5 March 2026 show. Mature states have more licensed extractors than demand, so distillate trades as a commodity and price falls faster than volume grows; this is the main reason the price leg is minus 1.4% a year.

The hemp redefinition takes about 1.0 point off volume. Public Law 119-37, approved on 12 November 2025, govinfo shows, excludes final hemp-derived products with more than 0.4 mg of total THC per container and cannabinoids synthesized outside the plant, with effect 365 days after signing, the Cannabis Regulators Association’s briefing of November 2025 explains. Hemp extractors that made distillate for delta-8 and delta-9 gummies lose most of that business unless states license it.

Schedule I status and supplier exits take about 0.4 points. The Drug Enforcement Administration’s order of 28 April 2026 moved FDA-approved marijuana products and state-licensed medical marijuana to Schedule III, but marijuana extract and adult-use marijuana stay in Schedule I, the Federal Register notice shows. Equipment supply also thinned: Agrify’s board approved “the discontinuation of the Company’s legacy extraction business” on 30 March 2025, closing its Precision Extraction, PurePressure, Lab Society and Cascade Sciences lines, its quarterly report on Form 10-Q states. These restraints are already netted into the 5.2% volume leg and minus 1.4% price leg above.

Where is cannabis extract made and sold: North America, Europe, Asia Pacific or Latin America?

North America leads, USD 5.27 billion or 78.0% of 2025 cannabis extraction value, a Douglas Insights estimate, on the United States state markets and Canada. Europe grows fastest, 7.5% a year, to USD 1.25 billion by 2035.

North America leads because licensed sales are large: Illinois sold USD 1.51 billion of adult-use cannabis in 2025, its Department of Financial and Professional Regulation’s release of 30 January 2026 shows, and Massachusetts sold more than USD 1.65 billion, the Cannabis Control Commission reported. California cut its cannabis excise tax from 19% to 15% from 1 October 2025, the Department of Tax and Fee Administration’s notice states. The region grows only 2.9% a year to USD 7.01 billion because prices keep falling and the hemp channel shrinks.

Europe, USD 607.7 million, grows 7.5% a year on German medical demand and on Swiss, Czech and Polish medical programmes. Germany’s cabinet adopted a Medical Cannabis Act amendment on 8 October 2025 that ends mail-order supply of medical flower and requires a personal consultation, the Federal Ministry of Health’s release states, which may shift some patients toward oils and extracts. Asia Pacific, USD 405.1 million, grows 5.0%: Thailand returned cannabis flower to prescription-only control on 26 June 2025, Tilleke & Gibbins reports, while Australia’s medical market keeps buying oils. Latin America, USD 337.6 million, grows 6.0% on Colombian and Uruguayan export extraction; the Middle East and Africa, USD 135.1 million, grow 5.5% on South African and Israeli supply. Regional values sum to USD 7.00 billion in 2026, 0.08% below the headline, and USD 9.76 billion in 2035, 0.22% above it.

Who leads cannabis extraction: Curaleaf, Trulieve, Green Thumb or contract processors?

No company holds more than about 4.5% of cannabis extraction value; Curaleaf leads with about USD 303.9 million in 2025, Douglas Insights estimates. The eight largest integrated operators hold about 21.2%, and contract extractors and smaller licensees hold the rest.

The shares are Douglas Insights estimates because operators do not report extraction revenue separately; we take the extract-based part of each company’s sales at the first-sale price. Curaleaf’s 2025 revenue was USD 1.27 billion, its results show; Green Thumb’s rose 3.4% to USD 1.18 billion, its release of 25 February 2026 shows; Trulieve’s was flat at USD 1.18 billion, its release of 26 February 2026 shows; and Verano’s fell 6% to USD 822 million, its results of 12 March 2026 show.

In Canada, SNDL’s revenue rose 2.8% to CAD 946.4 million in 2025 with cannabis revenue up 11.4% to CAD 406.8 million, its results of 12 March 2026 show, and Canopy Growth’s cannabis revenue rose 15% in its year to 31 March 2026, its results of 15 June 2026 show. The field is fragmented because marijuana cannot cross state lines, so each operator runs a separate extraction lab in each state, and because the exit of Agrify’s equipment lines in March 2025 left buyers to suppliers that are mostly private.

What does a kilogram of cannabis extract cost, and how fast is the price falling?

A kilogram of cannabis extract sells for about USD 3,650 at first sale in 2025, a Douglas Insights estimate blended across THC distillate, live resin, CO2 oil and CBD isolate, and the average falls 1.4% a year to about USD 3,170 in 2035.

The hemp price comes from the USDA report, which shows 9.49 million pounds of floral hemp produced for extraction in 2025; the Michigan prices come from the December 2025 report. Biomass is cheap; the value is added in extraction, refining and testing, which is why a kilogram of finished concentrate retails for more than three times a kilogram of flower. We model the blended first-sale price at USD 3,599 in 2026. Distillate falls fastest, live resin and solventless hold up, and CBD isolate stays the cheapest extract by far. A USD 100 fall in the 2035 average price would cut 2035 value by about USD 307 million at our 2035 volume.

Which rules govern cannabis extraction: solvent limits, the hemp law or rescheduling?

Three rule sets govern cannabis extraction: state residual-solvent and testing limits, the federal hemp definition in Public Law 119-37, and the Drug Enforcement Administration’s partial move of marijuana to Schedule III.

State testing rules set the cost of every batch. California caps butane, propane, ethanol, heptane, pentane, acetone and isopropyl alcohol at 5,000 micrograms per gram of extract, hexane at 290 and benzene, chloroform and four other Category I solvents at 1.0, under section 15718 of title 4 of the California Code of Regulations, Cornell’s copy of the regulation shows. Colorado’s Marijuana Enforcement Division lists revisions to Rule 3-335 on concentrate production and Rule 4-215 on contaminant testing in its 2026 regulatory agenda, with hearings expected in fall 2026. Tighter limits favour closed-loop systems and post-processing, which pushes small extractors toward contract processors.

Federal rules are the second and third layers. The hemp definition in Public Law 119-37, approved on 12 November 2025, govinfo shows, measures intermediate products at 0.3% combined total THC and caps final products at 0.4 mg per container, so a CBD extractor can still sell isolate and broad-spectrum oil but not delta-9 gummy inputs. On rescheduling, the Drug Enforcement Administration held a hearing from 29 June to 15 July 2026 on moving all marijuana to Schedule III, its rescheduling page shows, and the judge’s recommended decision was still pending in September 2026, Morgan Lewis reported. Full rescheduling would end the federal tax rule that blocks business deductions for Schedule I sellers, freeing cash for extraction equipment.

What if rescheduling arrives or hemp collapses: where does cannabis extraction land in 2035?

The cannabis extraction market ends 2035 between USD 7.05 billion and USD 12.87 billion across our three cases, around a base of USD 9.74 billion. Rescheduling and how far distillate prices fall set most of the spread.

In the slower case broader rescheduling fails, few states license intoxicating hemp after November 2026 and distillate prices keep falling at mature-market rates, taking 2.2 points off volume and 1.1 points off price. In the faster case adult-use marijuana moves to Schedule III by 2028, two or three large states such as Pennsylvania legalise adult use, and European medical systems shift to extracted oils, adding 2.0 points to volume and 0.9 points to price. One extra point of yearly revenue growth adds about USD 980 million to 2035 value; one point less removes about USD 899 million.

Douglas Exclusive: the Extraction Margin Gap

The Extraction Margin Gap is a Douglas Insights model built from 10 inputs in 7 government and company documents dated March 2025 to October 2026. It measures how much value is added between hemp or cannabis biomass and the finished extract on a store shelf.

The finding, a Douglas Insights estimate: hemp biomass sold for extraction at about USD 79 a kilogram in 2025, and at a typical 8% to 12% recovery a kilogram of crude oil needs roughly 8 to 12 kilograms of biomass, or about USD 630 to USD 950 of input. Michigan’s finished concentrate sold for about USD 6,820 a kilogram at retail. Our blended first-sale price of USD 3,650 sits between, so extraction, refining and testing add roughly three quarters of the first-sale price on top of the biomass. That margin is what attracts new extractors, and the number of licensed extractors in mature states is the reason the price leg is negative.

The gap changes how to read the market. Volume will keep rising as consumers buy vapes, concentrates and edibles rather than flower, but the operators that hold value will be those with brands, solventless craft lines or pharmaceutical-grade CO2 capacity for medical exports, not those selling commodity distillate by the litre.

How does the methodology turn 1,850 tonnes into USD 6.75 billion of cannabis extraction?

Our methodology multiplies about 1,850 tonnes of finished cannabis and hemp extract made worldwide in 2025 by a blended first-sale price of USD 3,650 a kilogram to reach USD 6.75 billion. Tonnes come from retail sales by format; price comes from four extract-type builds.

The model covers 5 regions, 5 extraction methods, 5 extract types and 5 end products, and uses 112 data points, 26 sourced and 86 modelled. Arithmetic: 1,850 tonnes x USD 3,650 = USD 6.75 billion; USD 6.75 billion x (1.052 x 0.986)^10 = USD 9.74 billion. Volume reaches about 1,946 tonnes in 2026 and 3,070 tonnes in 2035; price falls to USD 3,599 in 2026; 2026 value is USD 7.00 billion.

Two cross-checks agree. First, Michigan’s vapes and concentrates made up about 25% of adult-use sales in December 2025 and January 2026; 25% of the state’s USD 3.18 billion at a first-sale to retail ratio near 40%, a Douglas Insights estimate, gives about USD 318 million of vape and concentrate extract value in that one state, before edible and beverage inputs, which fits a North American total in the USD 5 billion range. Second, the USDA‘s 9.49 million pounds of floral hemp produced for extraction, at the recovery rates above, yields about 340 to 520 tonnes of crude hemp oil before refining, consistent with the hemp share in our tonnage. AI tools help draft the text and automated checks test the arithmetic and links; the Douglas Insights research desk chooses the sources, builds the model and approves publication, as our editorial standards explain.

Sources

1. USDA National Agricultural Statistics Service National Hemp Report 2025 (2026)
2. US Government Publishing Office Public Law 119-37 (2025)
3. Cannabis Regulators Association (via Oklahoma OMMA) CANNRA briefing on 2025 appropriations language on hemp (2025)
4. Federal Register Rescheduling of FDA-approved products, final order (2026)
5. Drug Enforcement Administration Marijuana rescheduling regulatory actions (2026)
6. Michigan Cannabis Regulatory Agency December 2025 monthly report (2026)
7. Colorado Department of Revenue Marijuana sales reports (2026)
8. Illinois Department of Financial and Professional Regulation Adult-use cannabis sales figures, Nov-Dec 2025 (2026)
9. Health Canada Data on cannabis for medical purposes and non-medical sales (2026)
10. Federal Ministry of Health, Germany Medical Cannabis Act amendment adopted by cabinet (2025)
11. US Securities and Exchange Commission Curaleaf fourth quarter and full-year 2025 results (2026)
12. US Securities and Exchange Commission Green Thumb Industries fourth quarter and full-year 2025 results (2026)
13. US Securities and Exchange Commission Agrify Form 10-Q, discontinued extraction business (2025)
14. California Code of Regulations (Cornell LII) 4 CCR section 15718, residual solvents and processing chemicals (2025)

What counts in the cannabis extraction market, and what is excluded?

The cannabis extraction market counts cannabinoid extracts from cannabis and hemp at their first sale out of the extraction step, including toll processing fees. Flower, pre-rolls, retail markups, vape hardware and stand-alone extraction equipment sales are excluded.

The by-method split covers hydrocarbon, ethanol, CO2, solventless and other methods and post-processing; the by-extract-type split covers distillate, hydrocarbon concentrates, CO2 and full-spectrum oils, solventless resin, and CBD isolate and crude; the by-end-product split covers vapes, concentrates, edibles and beverages, tinctures and medical oils, and topicals; the by-region split covers five regions. Value is counted where the extract is made. Retail sales of the finished medical products are sized in our Medical Marijuana Market report.